Skip to Main Content

Paper Details

Potently neutralizing human antibodies that block SARS-CoV-2 receptor binding and protect animals.
bioRxiv
35
2020
B cells, COV2-2130, COV2-2196, COV2-2916, COVID-19, CoV, S, S RBD, SARS, SARS-CoV, SARS-CoV-2, human, human ACE2, major antigenic sites, mice, spike (S) glycoprotein, trimeric S protein, wild, wild-type

Datasets

Release 1.2